Delayed-onset myocarditis following COVID-19

Lancet Respir Med. 2021 Apr;9(4):e32-e34. doi: 10.1016/S2213-2600(21)00085-0. Epub 2021 Feb 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • COVID-19 / complications*
  • COVID-19 / diagnosis
  • COVID-19 / immunology
  • COVID-19 / virology
  • COVID-19 Nucleic Acid Testing
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Myocarditis / blood
  • Myocarditis / diagnosis
  • Myocarditis / immunology*
  • Myocarditis / mortality
  • RNA, Viral / isolation & purification
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology*
  • SARS-CoV-2 / isolation & purification
  • Shock, Cardiogenic / blood
  • Shock, Cardiogenic / diagnosis
  • Shock, Cardiogenic / immunology*
  • Shock, Cardiogenic / mortality
  • Systemic Inflammatory Response Syndrome / blood
  • Systemic Inflammatory Response Syndrome / diagnosis
  • Systemic Inflammatory Response Syndrome / immunology*
  • Systemic Inflammatory Response Syndrome / mortality
  • Time Factors
  • Young Adult

Substances

  • Biomarkers
  • RNA, Viral

Associated data

  • ClinicalTrials.gov/NCT04340921